Efficacy and safety of bevacizumab with standard first-line fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer: First beat

被引：0

作者：

Rivera, F.

Cunningham, D. ^{[1
]}

Berry, S. ^{[2
]}

Kretzschmar, A. ^{[3
]}

Michael, M. ^{[4
]}

Dibartolomeo, M. ^{[5
]}

Mazier, M. ^{[6
]}

Andre, N. ^{[7
]}

Van Cutsem, E. ^{[8
]}

机构：

[1] Royal Marsden Hosp, Dept Med, Sutton, Surrey, England

[2] Sunnybrook Hlth Sci Ctr, Div Haematol Med Oncol, Toronto, ON M4N 3M5, Canada

[3] HELIOS Klin, Robert Rossle Klin, Charite, Berlin, Germany

[4] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia

[5] Ist Nazl Tumori, Div Med Oncol, Unit 2, I-20133 Milan, Italy

[6] Paraxel, Dept Stat, Paris, France

[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[8] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：17 / 17

页数：1

共 50 条

[41] Optimizing first-line chemotherapy for metastatic colorectal cancer
Adams, Richard A.
[J]. COLORECTAL CANCER, 2012, 1 (03) : 241 - 253
[42] Place of first-line palliative chemotherapy in patients with metastatic colorectal cancer
Hebbar, M
[J]. REVUE DE MEDECINE INTERNE, 1997, 18 : S364 - S367
[43] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
J Feliu
M J Safont
A Salud
F Losa
C García-Girón
C Bosch
P Escudero
R López
C Madroñal
M Bolaños
M Gil
A Llombart
J Castro-Carpeño
M González-Barón
[J]. British Journal of Cancer, 2010, 102 : 1468 - 1473
[44] Sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy
Maddalena, C.
Ponsiglione, A.
Camera, L.
Santarpia, L.
Pasanisi, F.
Bruzzese, D.
Panico, C.
Fiore, G.
Camardella, S.
Caramia, T.
Farinaro, A.
De Placido, S.
Carlomagno, C.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S178 - S178
[45] Bevacizumab plus XELOX as first-line therapy for patients with metastatic colorectal cancer
Gaspar, E.
Juarez Marroqui, A.
Vicent, J.
Llorca, C.
Orts, D.
Galan, A.
Barrajon, E.
Cervera Grau, J.
Giner, V.
Macia, S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[46] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
Feliu, J.
Safont, M. J.
Salud, A.
Losa, F.
Garcia-Giron, C.
Bosch, C.
Escudero, P.
Lopez, R.
Madronal, C.
Bolanos, M.
Gil, M.
Llombart, A.
Castro-Carpeno, J.
Gonzalez-Baron, M.
[J]. BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
[47] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
Bazarbashi, S.
Hakoun, A. M.
Gad, A. M.
Elshenawy, M. A.
Aljubran, A.
Alzahrani, A. M.
Eldali, A.
[J]. CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
[48] EFFECTIVENESS AND SAFETY OF FIRST-LINE BEVACIZUMAB PLUS FOLFIRI IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
Pinto, Ana Catarina
Teixeira, Margarida
Bonito, Nuno
Jacinto, Paula
Ribeiro, Joao
Gervasio, Helena
[J]. ANNALS OF ONCOLOGY, 2011, 22 : v98 - v98
[49] The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.
Yildiz, Ramazan
Buyukberber, Suleyman
Koca, Dogan
Korai, Lokman
Ciltas, Aydin
Unal, Olcun Umit
Gumus, Mahmut
Ozdemir, Nuriye
Dane, Faysal
Berk, Veil
Kaplan, Mehmet Ali
Elkiran, Tamer
Boruban, Melih Cern
Coskun, Ugur
Aydin, Dincer
Uncu, Dogan
Ozkan, Metin
Isikdogan, Abdurrahman
Benekli, Mustafa
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[50] Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
Gerger, Armin
El-Khoueiry, Anthony
Zhang, Wu
Yang, Dongyun
Singh, Harpreet
Bohanes, Pierre
Ning, Yan
Winder, Thomas
LaBonte, Melissa J.
Wilson, Peter M.
Benhaim, Leonor
Paez, David
El-Khoueiry, Rita
Absenger, Gudrun
Lenz, Heinz-Josef
[J]. CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5783 - 5792

← 1 2 3 4 5 →